236 related articles for article (PubMed ID: 11454642)
1. Specific glycosylation of alpha(1)-acid glycoprotein characterises patients with familial Mediterranean fever and obligatory carriers of MEFV.
Poland DC; Drenth JP; Rabinovitz E; Livneh A; Bijzet J; van het Hof B; van Dijk W
Ann Rheum Dis; 2001 Aug; 60(8):777-80. PubMed ID: 11454642
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum level and altered glycosylation of alpha 1-acid glycoprotein in hyperimmunoglobulinemia D and periodic fever syndrome: evidence for persistent inflammation.
Havenaar EC; Drenth JP; van Ommen EC; van der Meer JW; van Dijk W
Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 1):279-84. PubMed ID: 7554449
[TBL] [Abstract][Full Text] [Related]
3. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations.
Lachmann HJ; Sengül B; Yavuzşen TU; Booth DR; Booth SE; Bybee A; Gallimore JR; Soytürk M; Akar S; Tunca M; Hawkins PN
Rheumatology (Oxford); 2006 Jun; 45(6):746-50. PubMed ID: 16403826
[TBL] [Abstract][Full Text] [Related]
4. Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections.
Çakan M; Aktay Ayaz N; Keskindemirci G; Karadağ ŞG; Tanatar A; Sönmez HE
Clin Rheumatol; 2020 Jan; 39(1):249-253. PubMed ID: 31485845
[TBL] [Abstract][Full Text] [Related]
5. R202Q/M694V as novel MEFV gene mutations in chronic periodontitis and familial Mediterranean fever.
Fentoğlu Ö; Dinç G; Bağcı Ö; Doğru A; İlhan I; Kırzıoğlu FY; Orhan H
J Periodontal Res; 2017 Dec; 52(6):994-1003. PubMed ID: 28590056
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen gene polymorphisms [c.924C>T and IVS 8+14 G>A] in periodontitis and familial Mediterranean fever: A case-control study.
Fentoğlu Ö; Tülüceoğlu EE; Orhan H
J Periodontal Res; 2022 Apr; 57(2):371-380. PubMed ID: 34939186
[TBL] [Abstract][Full Text] [Related]
7. The relationship between the MEFV genotype, clinical features, and cytokine-inflammatory activities in patients with familial mediterranean fever.
Colak B; Gurlek B; Yegin ZA; Deger SM; Elbek S; Pasaoglu H; Dogan I; Ozturk MA; Unal S; Guz G
Ren Fail; 2008; 30(2):187-91. PubMed ID: 18300119
[TBL] [Abstract][Full Text] [Related]
8. Significance of MEFV gene R202Q polymorphism in Turkish familial Mediterranean fever patients.
Yigit S; Karakus N; Tasliyurt T; Kaya SU; Bozkurt N; Kisacik B
Gene; 2012 Sep; 506(1):43-5. PubMed ID: 22771921
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever.
Kallinich T; Wittkowski H; Keitzer R; Roth J; Foell D
Ann Rheum Dis; 2010 Apr; 69(4):677-82. PubMed ID: 19762364
[TBL] [Abstract][Full Text] [Related]
10. MEFV mutation analysis of familial Mediterranean fever in Japan.
Tomiyama N; Higashiuesato Y; Oda T; Baba E; Harada M; Azuma M; Yamashita T; Uehara K; Miyazato A; Hatta K; Ohya Y; Iseki K; Jinno Y; Takishita S
Clin Exp Rheumatol; 2008; 26(1):13-7. PubMed ID: 18328141
[TBL] [Abstract][Full Text] [Related]
11. MEFV and SAA1 genotype associations with clinical features of familial Mediterranean fever and amyloidosis in Armenia.
Atoyan S; Hayrapetyan H; Sarkisian T; Ben-Chetrit E
Clin Exp Rheumatol; 2016; 34(6 Suppl 102):72-76. PubMed ID: 27791951
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis-associated speck-like protein containing a CARD (ASC) expression profiles in familial Mediterranean fever (FMF) patients with different MEFV mutation patterns.
Nalbantoglu S; Tanyolac B; Berdeli A
Scand J Rheumatol; 2013; 42(2):159-62. PubMed ID: 22934972
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation?
Ozen S; Bakkaloglu A; Yilmaz E; Duzova A; Balci B; Topaloglu R; Besbas N
J Rheumatol; 2003 Sep; 30(9):2014-8. PubMed ID: 12966608
[TBL] [Abstract][Full Text] [Related]
14. Familial Mediterranean fever: new phenotypes.
Soriano A; Manna R
Autoimmun Rev; 2012 Nov; 12(1):31-7. PubMed ID: 22878273
[TBL] [Abstract][Full Text] [Related]
15. The significance of paired MEFV mutations in individuals without symptoms of familial Mediterranean fever.
Tunca M; Akar S; Hawkins PN; Booth SE; Sengül B; Yavuzşen TU; Oktem S; Soytürk M; Akkoç N; Booth DR
Eur J Hum Genet; 2002 Dec; 10(12):786-9. PubMed ID: 12461684
[TBL] [Abstract][Full Text] [Related]
16. Increased α1-3 fucosylation of α-1-acid glycoprotein (AGP) in pancreatic cancer.
Balmaña M; Giménez E; Puerta A; Llop E; Figueras J; Fort E; Sanz-Nebot V; de Bolós C; Rizzi A; Barrabés S; de Frutos M; Peracaula R
J Proteomics; 2016 Jan; 132():144-54. PubMed ID: 26563517
[TBL] [Abstract][Full Text] [Related]
17. Association between reduced levels of MEFV messenger RNA in peripheral blood leukocytes and acute inflammation.
Ustek D; Ekmekci CG; Selçukbiricik F; Cakiris A; Oku B; Vural B; Yanar H; Taviloglu K; Ozbek U; Gül A
Arthritis Rheum; 2007 Jan; 56(1):345-50. PubMed ID: 17195238
[TBL] [Abstract][Full Text] [Related]
18. alpha1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis.
Hashimoto S; Asao T; Takahashi J; Yagihashi Y; Nishimura T; Saniabadi AR; Poland DC; van Dijk W; Kuwano H; Kochibe N; Yazawa S
Cancer; 2004 Dec; 101(12):2825-36. PubMed ID: 15536618
[TBL] [Abstract][Full Text] [Related]
19. MEFV gene mutations in Egyptian patients with familial Mediterranean fever.
El Gezery DA; Abou-Zeid AA; Hashad DI; El-Sayegh HK
Genet Test Mol Biomarkers; 2010 Apr; 14(2):263-8. PubMed ID: 20151816
[TBL] [Abstract][Full Text] [Related]
20. Reduced MEFV messenger RNA expression in patients with familial Mediterranean fever.
Notarnicola C; Didelot MN; Koné-Paut I; Seguret F; Demaille J; Touitou I
Arthritis Rheum; 2002 Oct; 46(10):2785-93. PubMed ID: 12384939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
